Thesis (Ph. D.)--University of Iowa, 2007. / Thesis supervisor: Gregory C. Gray. Includes bibliographical references (leaves 94-105).

Thesis (Ph. D.)--University of Hong Kong, 2009. / Includes bibliographical references (leaves 131-151) Also available in print.

Thesis (MSc (Production Animal Studies)--University of Pretoria, 2008. / Includes bibliographical references. Also available in print format.

Thesis (Ph. D.)--University of Hong Kong, 2009. / Includes bibliographical references (leaves 131-151) Also available online.

Thesis (M. Phil.)--University of Hong Kong, 2010. / Includes bibliographical references (leaves 61-64). Also available in print.

Thesis (M. Phil.)--University of Hong Kong, 2006. / Also available online.

Thesis (Ph.D.)(Zoology)--University of Pretoria, 2007. / Includes summary. Includes bibliographical references. Available on the Internet via the World Wide Web.

Thesis (M.S.)--University of Delaware, 2009. / Principal faculty advisor: Calvin L. Keeler, Jr., Dept. of Animal & Food Sciences. Includes bibliographical references.

Magister Public Health - MPH / Avian Influenza (AI) is a contagious viral zoonotic disease with great public health implications and negative socioeconomic impact (WHO, 2006a). The highly pathogenic avian influenza (HPAI) infection is transmitted from birds to man mostly through contact with contaminated poultry and objects (INFOSAN, 2005), hence people who come in contact with birds such as live bird sellers (LBS) are the more vulnerable population (WHO, 2006a). Inadequate knowledge of AI health risks and poor practice of AI preventive measures amongst LBS increases the risk of spread of the infection in both humans and animals.The aim of this study was to describe and quantify the knowledge and practice of LBS with regards to avian influenza health risks and preventive activities in Agege, an urban area in Lagos State, Nigeria. / South Africa

Avian influenza H5N1 causes occasional but serious infections in humans and efforts to produce vaccines against this strain continue. Current influenza vaccines are prophylactic and utilize the two major antigens, hemagglutinin and neuraminidase. NP is an attractive alternative antigen because it is highly conserved across all influenza strains, has been shown to increase the rate of viral clearance, and potential therapeutic vaccines would elicit cytotoxic T lymophcyte responses in an infected person. The NP antigen from H5N1 was characterized using a variety of physiochemical methods to gain insights into both the biological and physical properties of the antigen which are important from a regulatory viewpoint when considering therapeutic vaccines. Results obtained to date show that NP is relatively unstable and indicate that the conformation of the H5N1 NP antigen is highly dependent upon purification procedure, buffer conditions, pH and the presence or absence of RNA. These factors will need to be clearly defined and taken into consideration when manufacturing and regulating NP vaccine preparations.